Most pharmacology efforts now focus on developing a vaccine to inoculate the population in order to stop the HPV virus from infecting the system. But this is not useful at all for those already affected with warts. It has therefore been necessary, at least for the first generation HPV vaccines, to focus on the HPV types found most frequently in cervical cancer. This consideration has led both companies to focus on HPV16 and HPV18, which account for about 70% of cases of cervical cancer.
Warts
are caused by a highly contagious virus known as the human papilloma
virus, or HPV. As warts are highly contagious they have become very
prevalent in the general population. They can occur virtually
anywhere on the body. If afflicted with warts, it becomes necessary
to eradicate the HPV infection to eliminate them.
Genital
warts cures must be able to eliminate both the visible symptoms and
the causative virus to be truly effective. Unfortunately, there are
few successful medical options available. Surgically removing warts
is the most common medical procedure. However, the patient is subject
to a painful surgical intervention which results in skin
damage/scarring along with the probability the warts will return.
Most
pharmacology efforts now focus on developing a vaccine to inoculate
the population in order to stop the HPV virus from infecting the
system. This is ideal for the pharmaceutical companies as it would of
course reap a monetary windfall of epic proportions for the drug
companies, but not useful at all for those already affected with
warts.
It
would be desirable for an HPV vaccine to have the ability to prevent
all cases of cervical cancer. It has therefore been necessary, at
least for the first generation HPV vaccines, to focus on the HPV
types found most frequently in cervical cancer. This consideration
has led both companies to focus on HPV16 and HPV18, which account for
about 70% of cases of cervical cancer.
When
considering appropriate end points for determining vaccine efficacy,
the most relevant end points recommended by an FDA vaccine advisory
panel were a reduction in the incidence of vaccine type-specific
persistent infections and of associated moderate- and high-grade
cervical dysplasias and carcinomas in situ.
It
is important to note that it would be unethical to use cervical
cancer as a primary end point for vaccine efficacy trials, as
cervical cancer screening can prevent the vast majority of cancer
through the identification of precancers, which are then treated.
Also, the interval between infection and the development of invasive
cancer usually takes more than 10 years.
When
fully vaccinated women who remained negative for infection throughout
the vaccination period were analyzed against the comparable placebo
cohort, the vaccine was 100% effective in preventing CIN2 associated
with HPV16 or HPV18 and also in preventing external genital warts
associated with HPV6 or HPV11.
Even
when the efficacy was compared starting 1 month after the first
immunization, protection for these end points was greater than 90%.
Thus systemic immunization with a subunit HPV vaccine can achieve a
high degree of protection in women against benign and premalignant
diseases induced by this sexually transmitted local infection of the
genital mucosa or skin.
The
medical community has not had success to develop a treatment to
successfully eradicate existing infections without causing extensive
skin damage, trauma, or relapse. Importantly, China has now banned
such vaccinations as they have found injecting a pathogen into your
system does just that, it stays in your system, remaining latent in
the joints, only to reappear in later years causing horrendous
arthritis and or auto immune disorders.
Skin
is comprised of the epidermis (outer layers), and the dermis which is
referred to as the true skin (inner layers). The epidermis has 7
layers which protect and surrounds the true skin. Because the true
skin is the reservoir of nourishment, it is the area where most
dermatological problems begin and where the root of a wart resides.
This
is why surgery to remove warts is so highly invasive, it must dig
deep through all dermal layers, only to yield unsuccessful results
when the warts reappear, despite best surgical efforts, the entire
infection is almost never entirely cut out. So, this method to cure
warts often fails as doctors are unable to remove the virus in its
entirety, since it commonly lodges itself deep in the dermal layers
of the skin.
As
the antiviral properties of AntiWarts-Rx
have the demonstrated ability to penetrate all layers of the skin and
enter the blood stream via topical application, they have received
considerable attention from the National Academy of Sciences and
medical professionals on a global scale.
Viruses
exhibit rapid rates of mutation which can make immunity difficult to
sustain. Once a cell is infected it is difficult to selectively
inhibit the virus without harming the host cell. As a result, much
interest has focused on plants as strong allies in restoring immune
strength and inhibiting the spread of viral diseases.
Some
of the most impressive results consistently achieved with medicinal
plants are in the elimination of warts. The antiviral activities of
our antiwarts treatments are well documented and principally due to
their direct effect to eradicate the HPV virus. To learn more, please
go to http://www.naturespharma.org.
| About the author |
staff of Nature Power Company, which is a network company dedicated to promoting customers' websites and developing softwares. You can go to the following websites to learn more about our natural organic products. http://www.bcured.net http://www.naturespharma.org |
| Additional articles about HPV |
|
|
| Please Rate This Article |
Number of ratings: 0
Rating: 0